Lilly reports robust Q4, full-year earnings

Indianapolis-based Eli Lilly and Co. reported fourth-quarter earnings early Thursday morning that topped Wall Street expectations, largely driven by sales of blockbuster medications including weight-loss drug Mounjaro.... Read More